Clinical Trials Directory

Trials / Completed

CompletedNCT06298500

Clinical Performance of HISTOACRYL® LAPFIX - CANNULA for Laparoscopic Inguinal Hernia Repair

Retrospective, Single Center Clinical Study on the Clinical Performance of Histoacryl® Lapfix - Cannula for Laparoscopic Inguinal Hernia Repair

Status
Completed
Phase
Study type
Observational
Enrollment
443 (actual)
Sponsor
Aesculap AG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this retrospective study is to identify the incidence of hernia recurrence following the application of Histoacryl® Lapfix - Cannula for laparoscopic mesh fixation in patients undergoing hernia repair surgery. All adult patients who underwent laparoscopic inguinal hernia repair with Histoacryl® Lapfix - Cannula in the period June 2018 - March 2021 at Hospital San Juan de Dios will be analysed. The investigator team will access electronical medical records for the cohort of patients identified.

Conditions

Interventions

TypeNameDescription
DEVICEhernia repair surgeryIn recent years, atraumatic mesh fixation with tissue adhesive has increasingly become the method of choice. It is the recommended mesh fixation method by the International Hernia Society Guidelines. In this study patients with inguinal hernia are treated by placing a prosthetic mesh in one of the layers of the abdominal wall to cover the weakness, the mesh is fixed by Histoacryl LapFix,

Timeline

Start date
2024-03-15
Primary completion
2025-05-07
Completion
2025-05-07
First posted
2024-03-07
Last updated
2025-08-20

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06298500. Inclusion in this directory is not an endorsement.